Boston Scientific (BSX) Tops Q2 EPS by 1c, Beats on Revenues; Boosts FY17 Revenue Guide Above Consensus & Raises FY17 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Boston Scientific (BSX) Tops Q2 EPS by 1c, Beats on Revenues; Boosts FY17 Revenue Guide Above Consensus & Raises FY17 EPS Outlook

Boston Scientific (BSX) PT Raised to $32 at Cowen

July 27, 2017 3:50 PM EDT

Cowen raised its price target on Boston Scientific (NYSE: BSX) to $32.00 (from $31.00) while maintaining a Outperform rating.

Management revised full year 2017 guidance and effectively kept the midpoint of the organic revenue guidance range intact at 5.8% while raising the EPS target by $0.01.

... More

Stifel Reiterates Buy on Boston Scientific (BSX) Following 2Q

July 27, 2017 1:41 PM EDT

Stifel reiterated a Buy rating and $32.00 price target on Boston Scientific (NYSE: BSX) following the company's 2Q. Revenue at $2.257 billion grew 6% reported and on organic basis, and 7% on an operational basis. BSX modestly raised the top-end of its previous 2017 organic sales growth... More